
【日本血栓止血学会サイト お役立ちリンク集】 ・用語集 ・研修医のお役立ち論文コンテンツ ・診療ガイドライン 本編は次ページより掲載しております。 日本血栓止血学会サイトに掲載しているおすすめコンテンツの リンクをご紹介します。 ・1)血栓止血の臨床-研修のために【第２版】(前編) 造血幹細胞移植後 TMA Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: TA-TMA


松井宏行 
Hiroyuki Matsui 
Yasuyuki Arai 
【日本血栓止血学会サイト お役立ちリンク集】 ・用語集 ・研修医のお役立ち論文コンテンツ ・診療ガイドライン 本編は次ページより掲載しております。 日本血栓止血学会サイトに掲載しているおすすめコンテンツの リンクをご紹介します。 ・1)血栓止血の臨床-研修のために【第２版】(前編) 造血幹細胞移植後 TMA Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: TA-TMA
・オーバービュー 1編 ・検査 14編 ・血小板・血管の異常による出血性疾患 12編 ・凝固・線溶系異常による出血性疾患 17編 ・出血性疾患の治療(血液製剤など) 8編 2018 年 29 巻 6 号 p. 537-764, 2018. ・2)血栓止血の臨床-研修のために【第２版】(後編) 2019 年 30 巻 1 号 p. 3-247, 2019. ・血栓性疾患 17編 ・血栓性疾患の治療薬 13編 ・血小板減少を伴う血栓性疾患 18編thrombotic microangiopathyallogeneic hematopietic stem cell transplantationcalcineurin inhibitor
要約：難治性造血器疾患に対する根治療法である同種造血幹細胞移植には，様々な合併症が併発することが知 られる．そのうち，血栓性微小血管症(thrombotic microangiopathy: TMA)は一旦発症すると高い確率で多臓器 不全に進行しうる，極めて重要な合併症である．その診断においては，血小板減少，溶血性貧血，微小循環障 害を含んだ複数の基準が提唱されているが，いずれかの徴候が現われた際には，早いタイミングでの暫定診断 が重要となる．治療としては，免疫抑制剤の適切なコントロールを含む厳重な全身管理が重要となるが，病態 生理に則った根治的な治療法は確立されていない．種々の支持療法技術の向上により，同種移植適応が拡大さ れる中，TMA の診断と治療に関しても，早急に最適化を目指すことが重要な課題である．

図 1 )が多い
1TTP ) と 溶血性尿毒症症候群(hemolytic uremic syndrome: HUS)がよく知られる．このうち， TTP は von Willebrand 因子(VWF)を切断するプロ テアーゼである a disintegrin and metalloprotease with thrombospondin domain(ADAMTS)13 の活性低下 と，それに伴う超高分子量 VWF 重合体(unusually 1 京都大学医学部附属病院血液内科 2 京都大学医学部附属病院検査部(輸血・細胞治療部門) ・細 胞療法センター *責任者連絡先： 京都大学医学部附属病院血液内科 〒 606-8507 京都市左京区聖護院川原町 54 Tel: 075-751-4964，Fax: 075-751-4963 E-mail: ysykrai@kuhp.kyoto-u.ac.jp large VWF multimer: UL-VWFM)の残存が原因とな る 2) BMT-CTN 毒性評価委員会による TA-TMA の重症度基準 7) Grade 1 破砕赤血球(+) Grade 2 破砕赤血球(+) ，腎障害(Cr ＜ 3×ULN) Grade 3 破砕赤血球(+) ，腎障害(Cr ＞ 3×ULN) 12) ． 3．TA-TMA の治療と予後 特発性 TTP に対しては，抗 ADAMTS13 抗体およ び UL-VWFM 除去と，正常な ADAMTS13 および VWF の補充を目的とした血漿交換療法が第一選択 であるが，病態が異なる TA-TMA に対しては血漿交 換の効果は限定的であり，推奨されない 9) 2,430 症例を対象とした解析で，臨床的に TA-TMA と診断されたのは 123 人で，100 日時点での累 積発症率は 5.0％(発症日中央値：移植後 36 日)で あった．TA-TMA を発症した症例は，そうでない症 図 1 血清 NETs 値と TA-TMA の関連 TA-TMA 発症群(TMA group)と，非発症群(non-TMA group)に分けて，血清 NETs を示す．移植後，全ての症例で NETs 値の上昇を認めるが，TA-TA-TMA について概説した．同種造血幹細胞 移植は，医療技術の向上とともに適応が広がりつつ ある一方で，合併症併発による治療関連死亡率はま 図 2 TA-TMA と予後の関連 TA-TMA 発症群(TMA group)と，非発症群(non-TMA group)に分けて，移植後の生存率を示す．移植後，TA-

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: Real progress or are we still waiting?. E D Batts, H M Lazarus, Bone Marrow Transplant. 40Batts ED, Lazarus HM: Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: Real progress or are we still waiting? Bone Marrow Transplant 40: 709-719, 2007.

Antibodies to von Willebrand factorcleaving protease in acute thrombotic thrombocytopenic purpura. H M Tsai, E C Lian, N Engl J Med. 339Tsai HM, Lian EC: Antibodies to von Willebrand factor- cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339: 1585-1594, 1998.

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. P I Tarr, C A Gordon, W L Chandler, Lancet. 365Tarr PI, Gordon CA, Chandler WL: Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073-1086, 2005.

Small vessels, big trouble in the kidneys and beyond: Hematopoietic stem cell transplantation-associated thrombotic microangiopathy. B L Laskin, J Goebel, S M Davies, S Jodele, Blood. 118Laskin BL, Goebel J, Davies SM, Jodele S: Small vessels, big trouble in the kidneys and beyond: Hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 118: 1452-1462, 2011.

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: A survey of the European Group for Blood and Marrow Transplantation (EBMT). T Ruutu, J Hermans, D Niederwieser, A Gratwohl, M Kiehl, L Volin, H Bertz, P Ljungman, D Spence, L F Verdonck, H G Prentice, A Bosi, Du Toit, C E Brinch, L Apperley, J F Party, Eclw , Br J Haematol. 118Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L, Bertz H, Ljungman P, Spence D, Verdonck LF, Prentice HG, Bosi A, Du Toit CE, Brinch L, Apperley JF, Party ECLW: Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: A survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 118: 1112-1119, 2002.

Diagnostic criteria for hematopoietic stem cell transplantassociated microangiopathy: Results of a consensus process by an International Working Group. T Ruutu, G Barosi, R J Benjamin, R E Clark, J N George, A Gratwohl, E Holler, M Iacobelli, K Kentouche, B Lammle, J L Moake, P Richardson, G Socie, Z Zeigler, D Niederwieser, T Barbui, European Group For, B Marrow, T European, L , Haematologica. 92Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, Holler E, Iacobelli M, Kentouche K, Lammle B, Moake JL, Richardson P, Socie G, Zeigler Z, Niederwieser D, Barbui T, European Group for B, Marrow T, European L: Diagnostic criteria for hematopoietic stem cell transplant- associated microangiopathy: Results of a consensus process by an International Working Group. Haematologica 92: 95- 100, 2007.

Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation. V T Ho, C Cutler, S Carter, P Martin, R Adams, M Horowitz, J Ferrara, R Soiffer, S Giralt, Biol Blood Marrow Transplant. 11Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, Ferrara J, Soiffer R, Giralt S: Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11: 571-575, 2005.

. 松本雅則：移植後, の病態と治療．臨床血液, 54松本雅則：移植後 TMA の病態と治療．臨床血液 54: 1958-1965, 2013.

Thrombotic complications associated with stem cell transplantation. Y Nadir, B Brenner, Blood Rev. 26Nadir Y, Brenner B: Thrombotic complications associated with stem cell transplantation. Blood Rev 26: 183-187, 2012.

Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. T A Fuchs, Kremer Hovinga, J A Schatzberg, D Wagner, D D Lammle, B , Blood. 120Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, Lammle B: Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangi- opathies. Blood 120: 1157-1164, 2012.

Neutrophil extracellular traps kill bacteria. V Brinkmann, U Reichard, C Goosmann, B Fauler, Y Uhlemann, D S Weiss, Y Weinrauch, A Zychlinsky, Science. 303Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A: Neutrophil extracellular traps kill bacteria. Science 303: 1532 -1535, 2004.

Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation. Y Arai, K Yamashita, K Mizugishi, T Watanabe, S Sakamoto, T Kitano, T Kondo, H Kawabata, N Kadowaki, A Takaori-Kondo, Biol Blood Marrow Transplant. 19Arai Y, Yamashita K, Mizugishi K, Watanabe T, Sakamoto S, Kitano T, Kondo T, Kawabata H, Kadowaki N, Takaori- Kondo A: Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 19: 1683 - 1689, 2013.

British Committee for Standards in H: Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. M Scully, B J Hunt, S Benjamin, R Liesner, P Rose, F Peyvandi, B Cheung, S J Machin, Br J Haematol. 158Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ, British Committee for Standards in H: Guidelines on the diagnosis and management of throm- botic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158: 323-335, 2012.

Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. W Y Au, E S Ma, T L Lee, S Y Ha, A T Fung, A K Lie, Y L Kwong, Br J Haematol. 137Au WY, Ma ES, Lee TL, Ha SY, Fung AT, Lie AK, Kwong YL: Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. Br J Haematol 137: 475-478, 2007.

Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin. M Sakai, T Ikezoe, K Bandobashi, K Togitani, A Yokoyama, Bone Marrow Transplant. 45Sakai M, Ikezoe T, Bandobashi K, Togitani K, Yokoyama A: Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombo- modulin. Bone Marrow Transplant 45: 803-805, 2010.

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: Response without significant toxicity in a high-risk population and factors predictive of outcome. P G Richardson, C Murakami, Jin Z Warren, D Momtaz, P Hoppensteadt, D Elias, A D Antin, J H Soiffer, R Spitzer, T Avigan, D Bearman, S I Martin, P L Kurtzberg, J Vredenburgh, J Chen, A R Arai, S Vogelsang, G Mcdonald, G B Guinan, E C , Blood. 100Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, Elias AD, Antin JH, Soiffer R, Spitzer T, Avigan D, Bearman SI, Martin PL, Kurtzberg J, Vredenburgh J, Chen AR, Arai S, Vogelsang G, McDonald GB, Guinan EC: Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: Response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 100: 4337-4343, 2002.

Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy. R Peffault De Latour, A Xhaard, V Fremeaux-Bacchi, P Coppo, A M Fischer, D Helley, G Socie, Br J Haematol. 161Peffault de Latour R, Xhaard A, Fremeaux-Bacchi V, Coppo P, Fischer AM, Helley D, Socie G: Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy. Br J Haematol 161: 279-280, 2013.

Diagnosis and management of thrombotic microangiopathy following hematopoietic stem cell transplantation. M Matsumoto, Journal of Hematopoietic Cell Transplantation. 5Matsumoto M: Diagnosis and management of thrombotic microangiopathy following hematopoietic stem cell trans- plantation. Journal of Hematopoietic Cell Transplantation 5: 74-81, 2016.

Massberg S: Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. M L Von Bruhl, K Stark, A Steinhart, S Chandraratne, Konrad I Lorenz, M Khandoga, A Tirniceriu, A Coletti, R Kollnberger, M Byrne, R A Laitinen, I Walch, A Brill, A Pfeiler, S Manukyan, D Braun, S Lange, P Riegger, J Ware, J Eckart, A Haidari, S Rudelius, M Schulz, C Echtler, K Brinkmann, V Schwaiger, M Preissner, K T Wagner, D D Mackman, N Engelmann, B , J Exp Med. 209von Bruhl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Kollnberger M, Byrne RA, Laitinen I, Walch A, Brill A, Pfeiler S, Manukyan D, Braun S, Lange P, Riegger J, Ware J, Eckart A, Haidari S, Rudelius M, Schulz C, Echtler K, Brinkmann V, Schwaiger M, Preissner KT, Wagner DD, Mackman N, Engelmann B, Massberg S: Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209: 819-835, 2012.

Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels. M Matsumoto, K Kawa, M Uemura, S Kato, H Ishizashi, A Isonishi, H Yagi, Y D Park, Y Takeshima, Y Kosaka, H Hara, S Kai, A Kanamaru, S Fukuhara, M Hino, M Sako, A Hiraoka, H Ogawa, J Hara, Y Fujimura, Bone Marrow Transplant. 40Matsumoto M, Kawa K, Uemura M, Kato S, Ishizashi H, Isonishi A, Yagi H, Park YD, Takeshima Y, Kosaka Y, Hara H, Kai S, Kanamaru A, Fukuhara S, Hino M, Sako M, Hiraoka A, Ogawa H, Hara J, Fujimura Y: Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restora- tion of von Willebrand factor plasma levels. Bone Marrow Transplant 40: 251-259, 2007.
